Rapid tranquilization for agitated patients in emergency psychiatric rooms: A randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone;Tranquilização rápida para pacientes agitados nos serviços de emergência psiquiátrica: Um ensaio clínico randomisado de olanzapina, ziprasidona, haloperidol mais prometazina, haloperidol mais midazolam e haloperidol em monoterapia

Revista Brasileira de Psiquiatria

Volumn 33, Issue 1, 2011, Pages 30-39

  Baldaçara, Leonardo ^a,b   Sanches, Marsal ^c,d   Cordeiro, Daniel Cruz ^c   Jackoswski, Andrea Parolin ^b  

^a UNIVERSIDADE FEDERAL DO TOCANTINS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c IRMANDADE DA SANTA CASA DE MISERICÓRDIA DE SÃO PAULO   (Brazil)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Antipsychotic agents; Emergencies; Psychomotor agitation; Psychotic disorders; Tranquilizing agents adverse effects

Indexed keywords

HALOPERIDOL; MIDAZOLAM; OLANZAPINE; PROMETHAZINE; ZIPRASIDONE;

ADULT; AGGRESSIVENESS; AGITATION; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EMERGENCY WARD; FEMALE; HALOPERIDOL PLUS PROMETHAZINE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OVERT AGITATION SEVERITY SCALE; OVERT AGRESSION SCALE; PSYCHIATRIC DEPARTMENT; PSYCHOSIS; RAMSAY SEDATION SCALE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEDATION; TRANQUILIZATION; TREATMENT OUTCOME;

ADULT; AGGRESSION; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EMERGENCY SERVICES, PSYCHIATRIC; FEMALE; HALOPERIDOL; HUMANS; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAMUSCULAR; MALE; MIDAZOLAM; PIPERAZINES; PROMETHAZINE; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS; THIAZOLES; TRANQUILIZING AGENTS;

EID: 79956325317     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462011000100008     Document Type: Article

References (43)

1. Expert Consensus Guideline Group. Treatment of schizophrenia 1999. The expert consensus guideline series. J Clin Psychiatry. 1999;60(Suppl 11):3-80.
2. TREC. Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine. BMJ. 2003;327(27):1-6.
3. Cunnane JG. Drug management of disturbed behaviour by psychiatrists. Psychiatr Bull. 1994;18:138-9.
4. Huf G, Coutinho ES, Adams CE. Haloperidol plus promethazine for agitated patients--a systematic review. Rev Bras Psiquiatr. 2009;31(3):265-70.
5. McAllister-Williams RH, Ferrier IN. Rapid tranquillisation: time for a reappraisal of options for parenteral therapy. Br J Psychiatry. 2002;180:485-9.
6. Allen MH, Currier GW. Use of restraints and pharmacotherapy in academic psychiatric emergency services. Gen Hosp Psychiatry. 2004;26(1):42-9.
7. Chouinard G, Safadi G, Beauclair L. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation. J Clin Psychopharmacol. 1994;14(6):377-84.
8. Jones B, Taylor CC, Meehan K. The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms. J Clin Psychiatry. 2001;62 Suppl 2:22-4.
9. Brook S, Lucey JV, Gunn KP. Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group. J Clin Psychiatry. 2000;61(12):933-41.
10. Raveendran NS, Tharyan P, Alexander J, Adams CE. Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. BMJ. 2007;335(7625):865.
11. Huf G, Coutinho ES, Adams CE. Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine. BMJ. 2007;335(7625):869.
12. Jangro WC, Preval H, Southard R, Klotz SG, Francis A. Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study. Child Adolesc Psychiatry Ment Health. 2009;3(1):9.
13. SPSS Inc. SPSS for Windows. Chicago; 1989-2004.
14. Allen MH, Currier GW, Carpenter D, Ross RW, Docherty JP. The expert consensus guideline series. Treatment of behavioral emergencies 2005. J Psychiatr Pract. 2005;11 Suppl 1:5-108; quiz 10-2.
15. Allen MH, Currier GW, Hughes DH, Docherty JP, Carpenter D, Ross R. Treatment of behavioral emergencies: a summary of the expert consensus guidelines. J Psychiatr Pract. 2003;9(1):16-38.
16. Currier GW, Allen MH, Bunney EB, Daniel DG, Francis A, Jagoda A, Zimbroff D. Intramuscular antipsychotics: clinical experience review. J Emerg Med. 2004;27(4 Suppl):S3-4; quiz S8.
17. Marco CA, Vaughan J. Emergency management of agitation in schizophrenia. Am J Emerg Med. 2005;23(6):767-76.
18. Battaglia J, Moss S, Rush J, Kang J, Mendoza RLeedom L, Dubin W, McGlynn C, Goodman L. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med. 1997;15(4):335-40.
19. Mantovani C, Migon M, Alheira F, Del-Ben C. Management of the violent or agitated patient. Rev Bras Psiquiatr. 2010;32(Supl 2):96-103.
20. Garza-Trevino ES, Hollister LE, Overall JE, Alexander WF. Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation. Am Journal Psychiatry. 1989;146(12):1598-601.
21. Bieniek SA, Ownby RL, Penalver A, Dominguez RA. A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy. 1998;18(1):57-62.
22. Huf G, Alexander J, Allen MH, Raveendran NS. Haloperidol plus promethazine for psychosis-induced aggression. Cochrane Database Syst Rev. 2009(3):CD005146.
23. Huf G, Coutinho ES, Adams CE; TREC-Rio trial. TREC-Rio trial: a randomised controlled trial for rapid tranquillisation for agitated patients in emergency psychiatric rooms [ISRCTN44153243]. BMC Psychiatry. 2002;2:11.
24. Huf G, Alexander J, Allen MH. Haloperidol plus promethazine for psychosis induced aggression. Cochrane Database Syst Rev. 2005(1):CD005146.
25. Alexander J, Tharyan P, Adams C, John T, Mol C, Philip J. Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine. Br J Psychiatry. 2004;185:63-9.
26. Alderfer BS, Allen MH. Treatment of agitation in bipolar disorder across the life cycle. J Clinical Psychiatry. 2003;64 (Suppl 4):3-9.
27. Thurston TA, Williams CG, Foshee SL. Reversal of a paradoxical reaction to midazolam with flumazenil. Anesth Analg. 1996;83(1):192.
28. Honan VJ. Paradoxical reaction to midazolam and control with flumazenil. Gastroint Endosc. 1994;40(1):86-8.
29. Martinez-Telleria A, Cano ME, Carlos R. Paradoxical reaction to midazolam after its use as a sedative in regional anesthesia. Revista Espanola de Anestesiologia y Reanimacion. 1992;39(6):379-80.
30. Short TG, Forrest P, Galletly DC. Paradoxical reactions to benzodiazepines--a genetically determined phenomenon? Anaesth Intensive Care. 1987;15(3):330-1.
31. Veser FH, Veser BD, McMullan JT, Zealberg J, Currier GW. Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial. J Psychiatr Pract. 2006;12(2):103-8.
32. Oliveira IR, Nunes PM, Coutinho DM, Sena EP. Review of the efficacy of placebo in comparative clinical trials between typical and atypical antipsychotics. Rev Bras Psiquiatr. 2008;31(1):52-6.
33. Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Eng J Med. 2009;360(3):225-35.
34. Wright P, Birkett M, David SR, Meehan K, Ferchland I, Alaka KJ, Saunders JC, Krueger J, Bradley P, San L, Bernardo M, Reinstein M, Breier A. Doubleblind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry. 2001;158(7):1149-51.
35. Satterthwaite TD, Wolf DH, Rosenheck RA, Gur RE, Caroff SN. A metaanalysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation. J Clin Psychiatry. 2008;69(12):1869-79.
36. Brook S, Walden J, Benattia I, Siu CO, Romano SJ. Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study. Psychopharmacology (Berl). 2005;178(4):514-23.
37. Battaglia J. Pharmacological management of acute agitation. Drugs. 2005;65(9):1207-22.
38. Andrezina R, Josiassen RC, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, Iwamoto T. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. Psychopharmacology (Berl). 2006;188(3):281-92.
39. Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, Taylor CC, Palmer R, Dossenbach M, Kiesler G, Brook S, Wright P. A doubleblind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry. 2002;59(5):441-8.
40. Daniel DG, Zimbroff DL, Swift RH, Harrigan EP. The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy. Int Clin Psychopharmacol. 2004;19(1):9-15.
41. Altamura AC, Sassella F, Santini A, Montresor C, Fumagalli S, Mundo E. Intramuscular preparations of antipsychotics: uses and relevance in clinical practice. Drugs. 2003;63(5):493-512.
42. Damsa C, Adam E, Lazignac C, De Gregorio F, Mihai A, Lejeune J, Sarasin F, Allen MH. Intramuscular olanzapine in patients with schizophrenia: an observational study in an emergency room. Bull Soc Sci Med Grand-Duche Luxemb. 2008(2):209-16.
43. Brook S. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia. J Clin Psychiatry. 2003;64(Suppl 19):13-8.